Epigenetics in health and disease
L Zhang, Q Lu, C Chang - Epigenetics in allergy and autoimmunity, 2020 - Springer
Epigenetic mechanisms, which include DNA methylation, histone modification, and
microRNA (miRNA), can produce heritable phenotypic changes without a change in DNA …
microRNA (miRNA), can produce heritable phenotypic changes without a change in DNA …
Targeted therapeutic strategies for triple-negative breast cancer
Y Li, Z Zhan, X Yin, S Fu, X Deng - Frontiers in oncology, 2021 - frontiersin.org
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer,
which is characterized by the absence of estrogen receptor (ER) and progesterone receptor …
which is characterized by the absence of estrogen receptor (ER) and progesterone receptor …
N6-methyladenine DNA modification in the human genome
Summary DNA N 6-methyladenine (6mA) modification is the most prevalent DNA
modification in prokaryotes, but whether it exists in human cells and whether it plays a role in …
modification in prokaryotes, but whether it exists in human cells and whether it plays a role in …
DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types
Lung, breast, colorectal, and prostate cancers are the most incident worldwide. Optimal
population-based cancer screening methods remain an unmet need, since cancer detection …
population-based cancer screening methods remain an unmet need, since cancer detection …
Pharmacogenomic biomarkers for improved drug therapy—recent progress and future developments
Much of the inter-individual variability in drug efficacy and risk of adverse reactions is due to
polymorphisms in genes encoding proteins involved in drug pharmacokinetics and …
polymorphisms in genes encoding proteins involved in drug pharmacokinetics and …
[图书][B] The handbook of biomarkers
KK Jain, KK Jain - 2010 - Springer
There are several definitions of biomarkers. A biomarker is a characteristic that can be
objectively measured and evaluated as an indicator of a physiological as well as a …
objectively measured and evaluated as an indicator of a physiological as well as a …
[HTML][HTML] Epigenetic and breast cancer therapy: promising diagnostic and therapeutic applications
The global burden of breast cancer (BC) is increasing significantly. This trend is caused by
several factors such as late diagnosis, limited treatment options for certain BC subtypes …
several factors such as late diagnosis, limited treatment options for certain BC subtypes …
MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer
Prostate cancer (PC) includes several phenotypes, from indolent to highly aggressive
cancer. Actual diagnostic and prognostic tools have several limitations, and there is a need …
cancer. Actual diagnostic and prognostic tools have several limitations, and there is a need …
Microfluidic technologies for anticancer drug studies
KP Valente, S Khetani, AR Kolahchi… - Drug discovery today, 2017 - Elsevier
Highlights•3D cell systems show high resistance to cytotoxic treatment compared with 2D
models.•Microfluidic systems allow cost-effective analysis of cytotoxic drugs.•Integration of …
models.•Microfluidic systems allow cost-effective analysis of cytotoxic drugs.•Integration of …
Long noncoding RNA Meg3 sponges miR-708 to inhibit intestinal tumorigenesis via SOCS3-repressed cancer stem cells growth
S Zhang, WW Ji, W Wei, LX Zhan, X Huang - Cell Death & Disease, 2021 - nature.com
Background Colorectal cancer (CRC) remains the most common gastrointestinal cancer and
a leading cause of cancer deaths worldwide, with most showing pathologies indicating the …
a leading cause of cancer deaths worldwide, with most showing pathologies indicating the …